In the current study, instead of recapitulating the hyperinsulinemia typically seen in type 2 diabetes, DIO-STZ mice instead develop hypoinsulinemia, which is attributed to STZ-induced loss of insulin-producing β-cells. The gene discussed is INS; the disease is Hyperinsulinemia.